Alliance Pharmaceuticals Limited
Matt Windeatt is an experienced finance professional currently serving as Group Financial Reporting Manager at Alliance Pharmaceuticals Limited since September 2019, following previous roles as Group Senior FP&A Analyst and Group FP&A Analyst. Prior to this position, Matt held the role of Executive in Transaction Services at Smith & Williamson from January 2019 to August 2019 and worked at EY as an Assurance Senior and Assurance Associate from September 2015 to January 2019. Matt's early career included an Industrial Placement at GSK in Biopharm Discovery R&D from August 2013 to August 2014. Educational credentials include a CA obtained from ICAS between 2015 and 2018 and a Bachelor of Science degree in Biological Sciences from the University of Leeds, earned from 2011 to 2015.
This person is not in any teams
This person is not in any offices
Alliance Pharmaceuticals Limited
1 followers
We are Alliance Pharma plc, an international healthcare group. Our purpose is to improve the lives of consumers and patients, through making available a range of clinically valuable healthcare products. Headquartered in the UK, we employ more than 250 people based in locations across Europe, North America, and the Asia Pacific region. Our core focus is on the marketing of Consumer Healthcare brands. We also have a smaller Prescription Medicines business, which operates alongside this. In total, we hold marketing rights to around 80 brands, with our revenues being generated from a mix of direct, distributor and e-commerce sales. With annual revenues in excess of £160m, good margins and strong cash generation, we’re financially successful and have a strong appetite for growth. Outsourcing all of our manufacturing and logistics activities allows us to remain asset-light and to focus on leveraging the operating platform we’ve built across EMEA, AMER and APAC, in order to maximise the value and reach of our brands. For more information on Alliance, please visit our website: www.alliancepharmaceuticals.com Adverse Event Reporting Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Pharmacovigilance at Alliance Pharmaceuticals (tel: 01249 466966, email: pharmacovigilance@alliancepharma.co.uk)